Transcranial Magnetic Stimulator Market Report and Forecast 2024-2032

Global Transcranial Magnetic Stimulator Market Report and Forecast 2024-2032


The global transcranial magnetic stimulator market was valued at USD 1.24 billion in 2023, driven by the increasing prevalence of neurological disorders such as schizophrenia and the rising geriatric population, leading to a surge in age-related brain disorders. The market is expected to grow at a CAGR of 9.1% during the forecast period 2024-2032, reaching a market value of USD 2.72 billion by 2032.

Global Transcranial Magnetic Stimulator Market Analysis

Transcranial magnetic stimulators are non-invasive medical devices used to stimulate nerve cells in the brain by applying magnetic fields. Primarily used in the treatment of neurological and psychiatric disorders, such as depression, Alzheimer’s disease, and Parkinson’s disease, these devices emit magnetic pulses that modulate brain activity. This technique has gained significant attention due to its ability to treat conditions resistant to medication, offering an alternative to more invasive therapies. Transcranial magnetic stimulation works by targeting specific regions of the brain associated with the disorder, and it is widely recognised for its safety and effectiveness. In recent years, the technology has expanded its applications in both clinical treatment and research, helping patients improve their quality of life without the need for surgery or drugs.

Market Drivers

Rising Prevalence of Neurological Disorders: The global increase in neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and depression is a key driver of the transcranial magnetic stimulator market. With a growing number of patients experiencing treatment-resistant conditions, transcranial magnetic stimulation is emerging as an effective and non-invasive alternative, driving demand.

Increasing Demand for Non-Invasive Treatments: Patients and healthcare providers are increasingly seeking non-invasive treatment options that offer fewer side effects compared to traditional surgical methods. Transcranial magnetic stimulation meets this need by providing a safe, effective, and non-invasive approach to treating neurological and psychiatric disorders, fuelling market growth.

Technological Advancements in Stimulation Devices: Continuous technological advancements in transcranial magnetic stimulation devices, such as improved targeting of specific brain regions and enhanced pulse control, are contributing to better clinical outcomes. These advancements make treatments more precise and effective, attracting more healthcare providers and patients.

Expanding Applications Beyond Depression: While depression is the most common condition treated with transcranial magnetic stimulation, the technology is now being applied to a broader range of neurological disorders, including epilepsy, anxiety, and migraines. The growing number of therapeutic applications is significantly driving market expansion.

Increased Mental Health Awareness: Growing awareness of mental health issues and the importance of innovative treatment options is propelling the adoption of transcranial magnetic stimulation. As mental health becomes a global priority, the need for non-invasive and effective treatment options is expected to rise, boosting market growth.

Challenges

Shortage of Skilled Professionals: The effective use of transcranial magnetic stimulators requires trained professionals with specialised skills. In many regions, there is a lack of such expertise, which can limit the availability of treatments and hinder the market’s growth potential.

Limited Insurance Coverage: Many healthcare insurance providers offer limited or no coverage for transcranial magnetic stimulation treatments. This lack of reimbursement policies in certain regions discourages patients from opting for the therapy, impeding the widespread adoption of the technology.

Complex Regulatory Approval Processes: Regulatory approval for transcranial magnetic stimulation devices can be lengthy and complex, slowing down the development and introduction of new products into the market. Compliance with stringent safety standards and lengthy clinical trials further complicate the approval process, limiting innovation.

Potential Side Effects: Although considered a safe and non-invasive procedure, transcranial magnetic stimulation can sometimes cause mild side effects, such as headaches, dizziness, or scalp discomfort. These side effects, although minor, may deter some patients from pursuing the treatment, thereby affecting its uptake.

Future Opportunities

Integration with Digital Health Platforms: The integration of transcranial magnetic stimulation with digital health platforms, such as telemedicine and remote monitoring, offers opportunities for enhanced patient care. This allows real-time tracking of treatment progress and adjustments, improving patient outcomes and creating new market opportunities.

Advancement in Personalised Stimulation Treatments: Personalised treatments are becoming increasingly popular in healthcare, and transcranial magnetic stimulation offers the potential for customised therapies tailored to individual patients. This focus on personalised care will drive demand for advanced devices that can target specific brain regions more precisely.

Expanding Mental Health Applications: The increasing use of transcranial magnetic stimulation in mental health, particularly for conditions such as post-traumatic stress disorder (PTSD) and anxiety, presents significant opportunities. As healthcare systems focus more on mental health, transcranial magnetic stimulation’s role in non-invasive treatments is expected to grow.

Increased Focus on Research and Clinical Trials: Ongoing research and clinical trials are exploring new applications for transcranial magnetic stimulation, such as treating chronic pain, enhancing cognitive functions, and even stroke recovery. These emerging therapeutic areas are expected to drive further adoption of the technology in both clinical and research settings.

Global Transcranial Magnetic Stimulator Market Trends

The industry is evolving rapidly, driven by technological innovations and advancements in various practices. As continuous research uncovers new insights across sectors, several key trends are emerging, shaping the future direction of the market. These trends are expected to significantly influence the landscape, improving outcomes, enhancing precision, and expanding access to advanced solutions across products, therapies, and services.

Growing Popularity of Deep Transcranial Magnetic Stimulation

Deep transcranial magnetic stimulation, which targets deeper brain structures, is gaining traction due to its effectiveness in treating severe psychiatric and neurological conditions. The ability to stimulate deeper areas of the brain makes it a preferred option for patients with treatment-resistant conditions, contributing to its rising popularity in clinical and research settings.

Increasing Application in Neurorehabilitation

Transcranial magnetic stimulation is being increasingly used in neurorehabilitation, particularly for patients recovering from strokes and brain injuries. By stimulating specific areas of the brain, transcranial magnetic stimulation promotes neural plasticity and helps in the recovery of motor functions, expanding its use beyond traditional psychiatric applications.

Development of Portable and Home-Use Devices

The development of portable transcranial magnetic stimulation devices is revolutionising the market, allowing patients to receive treatment in outpatient settings or at home. These portable devices are improving access to therapy, particularly for patients in remote or underserved regions, and are expected to drive future market growth.

Combination of Transcranial Magnetic Stimulation with Other Therapies

There is a growing trend towards combining transcranial magnetic stimulation with other treatment modalities, such as cognitive behavioural therapy or pharmacological treatments, to improve patient outcomes. These combination therapies are showing promise, particularly in the treatment of complex conditions like depression and anxiety.

Increased Use of Transcranial Magnetic Stimulation in Specialised Clinics

Specialised clinics that focus on neurological and psychiatric disorders are increasingly adopting transcranial magnetic stimulation as a primary treatment option. These clinics offer dedicated expertise and resources to administer the therapy, contributing to the growing demand for transcranial magnetic stimulators.

Rising Focus on Precision Medicine

The trend towards precision medicine, which tailors treatment to individual patient needs, is influencing the transcranial magnetic stimulator market. Advanced devices that allow for targeted and customised brain stimulation are increasingly being developed, aligning with the broader healthcare shift towards personalised therapies.

Global Transcranial Magnetic Stimulator Market Segmentation

Market Breakup by Type

Deep Transcranial Magnetic Stimulation

Repetitive Transcranial Magnetic Stimulation

Others

The global transcranial magnetic stimulator market is categorised into deep transcranial magnetic stimulation, repetitive transcranial magnetic stimulation, and others. Deep transcranial magnetic stimulation provides more profound brain stimulation, particularly suitable for treatment-resistant psychiatric and neurological conditions. Repetitive transcranial magnetic stimulation, on the other hand, is widely used for treating various disorders such as depression and anxiety by delivering repeated magnetic pulses to regulate brain activity. Both types play a crucial role in modern neurotherapies, with increasing clinical applications and research interest driving the demand for advanced devices.

Market Breakup by Application

Alzheimer’ Disease

Depression

Parkinson’s Disease

Epilepsy

Others

The market is segmented by application into Alzheimer’s disease, depression, Parkinson’s disease, epilepsy, and others. Depression remains the largest application area, with transcranial magnetic stimulation widely recognised as an effective treatment for patients who do not respond to traditional medications. The technology is also gaining traction in treating other neurological conditions like Alzheimer’s and epilepsy, with research demonstrating its potential to improve cognitive functions and reduce symptoms, driving the broader adoption of transcranial magnetic stimulation across multiple therapeutic fields.

Market Breakup by End User

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Others

End users of transcranial magnetic stimulator devices include hospitals, specialty clinics, ambulatory surgical centres, and other healthcare facilities. Hospitals dominate this segment due to their ability to provide complex, advanced neurological treatments using cutting-edge technologies. Specialty clinics, particularly those focused on mental health and neurorehabilitation, are also significant users of transcranial magnetic stimulators, offering targeted treatments for specific conditions. Ambulatory surgical centres contribute to the market by providing non-invasive treatments in an outpatient setting, increasing patient access to this innovative therapy.

Market Breakup by Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

The global transcranial magnetic stimulator market is divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high awareness of cutting-edge therapies, and strong investment in neurological research. Europe follows closely, with significant adoption of non-invasive treatments for neurological disorders. Asia Pacific is expected to witness rapid growth due to rising awareness, improving healthcare access, and increasing demand for non-invasive treatments. Latin America, the Middle East and Africa regions also present growth opportunities, supported by improving healthcare systems and growing interest in innovative medical technologies.

Global Transcranial Magnetic Stimulator Market Competitive Landscape

The competitive landscape of the global transcranial magnetic stimulator market includes major players such as BrainsWay Ltd., Neuronetics, Inc., Magstim Co. Ltd., MagVenture A/S, Neurosoft S.A., eNeura Inc., Nexstim Plc, Mag & More GmbH, and Salience TMSranscranial Magnetic Stimulator. These companies focus on advancing transcranial magnetic stimulation technology, expanding their product offerings, and engaging in strategic partnerships to strengthen their market presence globally.

Key Questions Answered in the Report

What are the primary drivers contributing to the growth of the global transcranial magnetic stimulator market?

How does deep transcranial magnetic stimulation differ from other forms of brain stimulation?

What challenges do manufacturers face in the transcranial magnetic stimulator market?

How does the rising demand for non-invasive treatments impact the market for transcranial magnetic stimulators?

What opportunities exist for expanding transcranial magnetic stimulation in mental health treatments?

How is the development of portable transcranial magnetic stimulators improving patient accessibility?

What role do combination therapies play in enhancing the efficacy of transcranial magnetic stimulation?

How is transcranial magnetic stimulation being utilised in neurorehabilitation, and what impact does it have on patient recovery?

What are the key regional markets for transcranial magnetic stimulators, and why are they dominant?

How is the focus on mental health awareness driving demand for transcranial magnetic stimulation treatments?

What competitive strategies are companies employing to strengthen their positions in the global transcranial magnetic stimulator market?

Key Benefits for Stakeholders

The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global transcranial magnetic stimulator market from 2017-2032.

The research report provides the latest information on the market drivers, challenges, and opportunities in the global transcranial magnetic stimulator market.

The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.

Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition within the global transcranial magnetic stimulator industry and its attractiveness.

The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Transcranial Magnetic Stimulator Market Overview
3.1 Global Transcranial Magnetic Stimulator Market Historical Value (2017-2023)
3.2 Global Transcranial Magnetic Stimulator Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Transcranial Magnetic Stimulator Market Landscape*
5.1 Global Transcranial Magnetic Stimulator Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Transcranial Magnetic Stimulator Market: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Application
6 Global Transcranial Magnetic Stimulator Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Transcranial Magnetic Stimulator Market Segmentation (2017-2032)
7.1 Global Transcranial Magnetic Stimulator Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Deep Transcranial Magnetic Stimulation
7.1.3 Repetitive Transcranial Magnetic Stimulation
7.1.4 Others
7.2 Global Transcranial Magnetic Stimulator Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Alzheimer’ Disease
7.2.3 Depression
7.2.4 Parkinson’s Disease
7.2.5 Epilepsy
7.2.6 Others
7.3 Global Transcranial Magnetic Stimulator Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Ambulatory Surgical Centers
7.3.5 Others
7.4 Global Transcranial Magnetic Stimulator Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Transcranial Magnetic Stimulator Market (2017-2032)
8.1 North America Transcranial Magnetic Stimulator Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Deep Transcranial Magnetic Stimulation
8.1.3 Repetitive Transcranial Magnetic Stimulation
8.1.4 Others
8.2 North America Transcranial Magnetic Stimulator Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Alzheimer’ Disease
8.2.3 Depression
8.2.4 Parkinson’s Disease
8.2.5 Epilepsy
8.2.6 Others
8.3 North America Transcranial Magnetic Stimulator Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgical Centers
8.3.5 Others
8.4 North America Transcranial Magnetic Stimulator Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Transcranial Magnetic Stimulator Market (2017-2032)
9.1 Europe Transcranial Magnetic Stimulator Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Deep Transcranial Magnetic Stimulation
9.1.3 Repetitive Transcranial Magnetic Stimulation
9.1.4 Others
9.2 Europe Transcranial Magnetic Stimulator Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Alzheimer’ Disease
9.2.3 Depression
9.2.4 Parkinson’s Disease
9.2.5 Epilepsy
9.2.6 Others
9.3 Europe Transcranial Magnetic Stimulator Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgical Centers
9.3.5 Others
9.4 Europe Transcranial Magnetic Stimulator Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Transcranial Magnetic Stimulator Market (2017-2032)
10.1 Asia Pacific Transcranial Magnetic Stimulator Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Deep Transcranial Magnetic Stimulation
10.1.3 Repetitive Transcranial Magnetic Stimulation
10.1.4 Others
10.2 Asia Pacific Transcranial Magnetic Stimulator Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Alzheimer’ Disease
10.2.3 Depression
10.2.4 Parkinson’s Disease
10.2.5 Epilepsy
10.2.6 Others
10.3 Asia Pacific Transcranial Magnetic Stimulator Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgical Centers
10.3.5 Others
10.4 Asia Pacific Transcranial Magnetic Stimulator Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Transcranial Magnetic Stimulator Market (2017-2032)
11.1 Latin America Transcranial Magnetic Stimulator Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Deep Transcranial Magnetic Stimulation
11.1.3 Repetitive Transcranial Magnetic Stimulation
11.1.4 Others
11.2 Latin America Transcranial Magnetic Stimulator Market (2017-2032) Application
11.2.1 Market Overview
11.2.2 Alzheimer’ Disease
11.2.3 Depression
11.2.4 Parkinson’s Disease
11.2.5 Epilepsy
11.2.6 Others
11.3 Latin America Transcranial Magnetic Stimulator Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgical Centers
11.3.5 Others
11.4 Latin America Transcranial Magnetic Stimulator Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Transcranial Magnetic Stimulator Market (2017-2032)
12.1 Middle East and Africa Transcranial Magnetic Stimulator Market (2017-2032) by Type
12.1.1 Market Overview
12.1.2 Deep Transcranial Magnetic Stimulation
12.1.3 Repetitive Transcranial Magnetic Stimulation
12.1.4 Others
12.2 Middle East and Africa Transcranial Magnetic Stimulator Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Alzheimer’ Disease
12.2.3 Depression
12.2.4 Parkinson’s Disease
12.2.5 Epilepsy
12.2.6 Others
12.3 Middle East and Africa Transcranial Magnetic Stimulator Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgical Centers
12.3.5 Others
12.4 Middle East and Africa Transcranial Magnetic Stimulator Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership and Collaborations
17.3 Analysis by Joint Ventures
17.4 Analysis by Leading Players
17.5 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 BrainsWay Ltd .
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 Neuronetics, Inc .
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 Magstim Co . Ltd.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 MagVenture A/ S
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 Neurosoft S. A.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 eNeura Inc .
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Nexstim Plc
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 Mag & More GmbH
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Mag & More GmbH
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certificationsḥr̥
18.11 Salience TMS
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Development
18.11.5 Certifications
19 Global Transcranial Magnetic Stimulator Market – Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings